Global law firm White & Case LLP has advised Groupe Industriel Marcel Dassault (GIMD), a holding company controlled by the Dassault family, on the sale of 600,000 shares in bioMérieux, representing approximately 0.5 percent of bioMérieux's share capital.
bioMérieux is a world leader in the field of in vitro diagnostics and is listed on the regulated market of Euronext Paris.
The disposal was carried out via an institutional private placement to qualified investors by way of an accelerated bookbuild for a total amount of approximately €49 million. Following this placement, GIMD retains 4.6 percent of the share capital of bioMérieux and its representation on bioMérieux's board of directors.
The placement was managed by BNP Paribas, as sole Global Coordinator and sole Bookrunner.
The White & Case team in Paris which advised on the transaction was led by partner Thomas Le Vert and included partner Max Turner, with support from associate Isabelle Touré-Farah.
For more information please speak to your local media contact.